A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : ESSDAI

Search Conditions:
Search Keyword : ESSDAI
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: ESSDAI
Appearance Frequency: 78 time(s)
Long forms: 6

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
EULAR Sjogren's Syndrome Disease Activity Index
(42 times)
Rheumatology
(22 times)
pSS (28 times)
ESSPRI (15 times)
SS (8 times)
2012 Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjogren's syndrome treated with rituximab.
EULAR SS Disease Activity Index
(16 times)
Rheumatology
(10 times)
pSS (8 times)
SS (5 times)
ESSPRI (3 times)
2010 Primary Sjogren's syndrome activity and damage indices comparison.
European League Against Rheumatism Sjogren's Syndrome Disease Activity Index
(16 times)
Rheumatology
(12 times)
pSS (9 times)
SS (6 times)
ELISA (3 times)
2010 Accurate detection of changes in disease activity in primary Sjogren's syndrome by the European League Against Rheumatism Sjogren's Syndrome Disease Activity Index.
EULAR primary Sjogren's syndrome disease activity
(2 times)
Rheumatology
(2 times)
EULAR (2 times)
SS (2 times)
ESSPRI (1 time)
2015 Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
effect by ianalumab was observed across the primary clinical outcome
(1 time)
Rheumatology
(1 time)
EOS (1 time)
ESSPRI (1 time)
pSS (1 time)
2019 Treatment of primary Sjogren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity.
epidemiology, classification criteria, systemic activity scoring
(1 time)
Rheumatology
(1 time)
pSS (1 time)
RCTs (1 time)
2016 Treatment of primary Sjogren syndrome.